Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by harposon Jun 15, 2017 1:17pm

292 Views

Post# 26366934

Caveat dropped

Did you notice that RW dropped the caveat that was in the other release. This research allows Theralase to successfully commercialize. No caveat saying when Effiacy is proven.
In other words, this tech announced today is getting commercialized by Theralase regardless of efficacy. Possibly huge revenues.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal